Table 1.
Characteristics, biochemistry and etiology of HCC patients (n = 145) n (%)
| Risk factor | Value |
| Age ± SD (yr) | 58 ± 11 |
| Male | 107 (73.79) |
| ALT | 61 (42.1) |
| AST | 61 (42.1) |
| Alkaline phosphatase | 145 (100) |
| Bilirubin | 145 (100) |
| AFP elevation | 125 (86.2) |
| Cirrhosis present | 98 (67.58) |
| HBsAg-positive (alone) | 18 (12.41) |
| Anti-HBc-positive (alone) | 2 (1.37) |
| Anti-HBs-positive | 10 (6.89) |
| HBV-DNA PCR-positive (alone) | 26 (17.93) |
| Anti-HCV-positive (alone) | 92 (63.44) |
| HCV-RNA PCR-positive | 83 (57.24) |
| HBV- and HCV-positive | 19 (13.10) |
| No known etiology | 6 (4.13) |
HCC: Hepatocellular carcinoma; ALT: Alanine aminotransferase; AST: Aminotransferase; AFP: α-fetoprotein; HCV: Hepatitis C virus; HBV: Hepatitis B virus.